MetLife Investment Advisors »

Benitec Biopharma shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Benitec Biopharma (BNTC) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Benitec Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Benitec Biopharma held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Benitec Biopharma by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $132k 9.4k 14.03
2025-06-30 $110k 9.4k 11.70

More positions owned by MetLife Investment Advisors

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Inc Class A Cl A (META)
Alphabet Inc Class A Cap Stk Cl (GOOGL)
Tesla Motors (TSLA)
Alphabet Inc Class C Cap Stk Cl (GOOG)
Berkshire Hathaway Inc Class B Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Vanguard Short-term Bond Index Fun Short Trm (BSV)
Eli Lilly & Co. (LLY)
Visa Inc Class A Com Cl A (V)
Netflix (NFLX)

View all positions for MetLife Investment Advisors

Top funds holding Benitec Biopharma

Suvretta Capital Management
Henderson Group
Franklin Resources
Adage Capital Partners GP
Vanguard Group
BlackRock
Nantahala Capital Management
Infinitum Asset Management
Geode Capital Management
Silverarc Capital Management
Schonfeld Strategic Advisors
State Street Corporation
Goldman Sachs Group
AWM Investment Company
Ameriprise Financial

View all funds holding Benitec Biopharma